StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Pharma-Bio Serv's ebitda for the twelve months ending Jul 31, 2026 was -$97.01K. For fiscal 2025 it was -$577.80K. The highest annual figure on record is $6.42M in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$577.80K–
FY2024Oct 31, 2024-$1.26M-208.5%
FY2023Oct 31, 2023$1.17M-4.9%
FY2022Oct 31, 2022$1.23M–
FY2021Oct 31, 2021-$3.78M-263.5%
FY2020Oct 31, 2020$2.31M+28.7%
FY2019Oct 31, 2019$1.80M–
FY2018Oct 31, 2018-$1.19M–
FY2017Oct 31, 2017-$670.14K-403.5%
FY2016Oct 31, 2016$220.80K-89.7%
FY2015Oct 31, 2015$2.14M-34.0%
FY2014Oct 31, 2014$3.24M-49.5%
FY2013Oct 31, 2013$6.42M+6.0%
FY2012Oct 31, 2012$6.06M+60.5%
FY2011Oct 31, 2011$3.77M+305.0%
FY2010Oct 31, 2010$931.60K–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026-$58.13K–
Q2 FY2026CQ1 2026Apr 30, 2026$158.32K–
Q1 FY2026CQ4 2025Jan 31, 2026-$79.74K–
Q4 FY2025CQ3 2025Oct 31, 2025-$117.46K–
Q3 FY2025CQ2 2025Jul 31, 2025-$298.13K–
Q2 FY2025CQ1 2025Apr 30, 2025-$79.46K–
Q1 FY2025CQ4 2024Jan 31, 2025-$82.75K–
Q4 FY2024CQ3 2024Oct 31, 2024-$148.20K–
Q3 FY2024CQ2 2024Jul 31, 2024-$377.19K-179.9%
Q2 FY2024CQ1 2024Apr 30, 2024-$307.87K-178.3%
Q1 FY2024CQ4 2023Jan 31, 2024-$431.01K-225.0%
Q4 FY2023CQ3 2023Oct 31, 2023-$44.37K-104.2%
Q3 FY2023CQ2 2023Jul 31, 2023$471.87K–
Q2 FY2023CQ1 2023Apr 30, 2023$393.25K–
Q1 FY2023CQ4 2022Jan 31, 2023$344.76K-9.0%
Q1 FY2022CQ4 2021Jul 31, 2022$1.04M+268.2%
Q2 FY2022CQ1 2022Apr 30, 2022-$382.47K-212.3%
Q4 FY2021CQ3 2021Oct 31, 2021-$4.78M-2878.3%
Q3 FY2021CQ2 2021Jul 31, 2021$378.67K-54.9%
Q2 FY2021CQ1 2021Apr 30, 2021$283.61K-61.8%
Q1 FY2021CQ4 2020Jan 31, 2021$340.55K-38.9%
Q4 FY2020CQ3 2020Oct 31, 2020$172.18K-61.9%
Q3 FY2020CQ2 2020Jul 31, 2020$839.89K+117.7%
Q2 FY2020CQ1 2020Apr 30, 2020$741.96K+48.8%
Q1 FY2020CQ4 2019Jan 31, 2020$557.79K+12.0%
Q4 FY2019CQ3 2019Oct 31, 2019$451.85K-10.9%
Q3 FY2019CQ2 2019Jul 31, 2019$385.82K-48.0%
Q2 FY2019CQ1 2019Apr 30, 2019$498.77K+3880.3%
Q1 FY2019CQ4 2018Jan 31, 2019$497.86K–
Q4 FY2018CQ3 2018Oct 31, 2018$507.31K–
Q3 FY2018CQ2 2018Jul 31, 2018$742.30K–
Q2 FY2018CQ1 2018Apr 30, 2018$12.53K–
Q1 FY2018CQ4 2017Jan 31, 2018-$2.45M–
Q4 FY2017CQ3 2017Oct 31, 2017-$65.66K–
Q3 FY2017CQ2 2017Jul 31, 2017-$106.03K–
Q2 FY2017CQ1 2017Apr 30, 2017-$223.92K–
Q1 FY2017CQ4 2016Jan 31, 2017-$274.54K–
Q4 FY2016CQ3 2016Oct 31, 2016-$368.26K–
Q3 FY2016CQ2 2016Jul 31, 2016-$43.11K–

More Pharma-Bio Serv figures

See a number that looks wrong?